185 related articles for article (PubMed ID: 34642262)
1. Whole-exome sequencing of rectal cancer identifies locally recurrent mutations in the Wnt pathway.
Yang Y; Gu X; Li Z; Zheng C; Wang Z; Zhou M; Chen Z; Li M; Li D; Xiang J
Aging (Albany NY); 2021 Oct; 13(19):23262-23283. PubMed ID: 34642262
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
[TBL] [Abstract][Full Text] [Related]
3. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
[TBL] [Abstract][Full Text] [Related]
4. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
[TBL] [Abstract][Full Text] [Related]
5. Ca
Kumar R; Raman R; Kotapalli V; Gowrishankar S; Pyne S; Pollack JR; Bashyam MD
J Mol Med (Berl); 2018 Feb; 96(2):135-146. PubMed ID: 29124284
[TBL] [Abstract][Full Text] [Related]
6. Whole exome sequencing in recurrent early pregnancy loss.
Qiao Y; Wen J; Tang F; Martell S; Shomer N; Leung PC; Stephenson MD; Rajcan-Separovic E
Mol Hum Reprod; 2016 May; 22(5):364-72. PubMed ID: 26826164
[TBL] [Abstract][Full Text] [Related]
7. The role of surgery for locally recurrent and second recurrent rectal cancer with metastatic disease.
Tanaka A; Uehara K; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
Surg Oncol; 2020 Dec; 35():328-335. PubMed ID: 32979698
[TBL] [Abstract][Full Text] [Related]
8. Uncovering potential single nucleotide polymorphisms, copy number variations and related signaling pathways in primary Sjogren's syndrome.
Qi X; Wang XQ; Jin L; Gao LX; Guo HF
Bioengineered; 2021 Dec; 12(2):9313-9331. PubMed ID: 34723755
[TBL] [Abstract][Full Text] [Related]
9. Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy.
Yang J; Lin Y; Huang Y; Jin J; Zou S; Zhang X; Li H; Feng T; Chen J; Zuo Z; Zheng J; Li Y; Gao G; Wu C; Tan W; Lin D
Theranostics; 2019; 9(23):6856-6866. PubMed ID: 31660073
[TBL] [Abstract][Full Text] [Related]
10. Molecular typing and mutational characterization of rectal neuroendocrine neoplasms.
Duan X; Zhao M; Yin X; Mi L; Shi J; Li N; Han X; Han G; Wang J; Hou J; Yin F
Cancer Med; 2023 Aug; 12(15):16207-16220. PubMed ID: 37387515
[TBL] [Abstract][Full Text] [Related]
11. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
[TBL] [Abstract][Full Text] [Related]
12. Rectal cancer sub-clones respond differentially to neoadjuvant therapy.
Frydrych LM; Ulintz P; Bankhead A; Sifuentes C; Greenson J; Maguire L; Irwin R; Fearon ER; Hardiman KM
Neoplasia; 2019 Oct; 21(10):1051-1062. PubMed ID: 31521947
[TBL] [Abstract][Full Text] [Related]
13. Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
Westberg K; Palmer G; Hjern F; Nordenvall C; Johansson H; Holm T; Martling A
Br J Surg; 2017 Dec; 104(13):1866-1873. PubMed ID: 29023631
[TBL] [Abstract][Full Text] [Related]
14. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
15. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
[TBL] [Abstract][Full Text] [Related]
16. Age-related differences in morbidity and mortality after surgery for primary clinical T4 and locally recurrent rectal cancer.
Ketelaers SHJ; Voogt ELK; Simkens GA; Bloemen JG; Nieuwenhuijzen GAP; de Hingh IHJ; Rutten HJT; Burger JWA; Orsini RG
Colorectal Dis; 2021 May; 23(5):1141-1152. PubMed ID: 33492750
[TBL] [Abstract][Full Text] [Related]
17. The clinical relevance of indeterminate lung nodules in patients with locally recurrent rectal cancer.
van Rees JM; Höppener DJ; Hagemans JAW; Rothbarth J; Grünhagen DJ; Nuyttens JJME; van Meerten E; de Vries M; Verhoef C
Eur J Surg Oncol; 2021 Jul; 47(7):1616-1622. PubMed ID: 33446352
[TBL] [Abstract][Full Text] [Related]
18. Treatment and subsequent prognosis in locally recurrent rectal cancer: a multicenter retrospective study of 498 patients.
Matsuyama T; Yamauchi S; Masuda T; Kikuchi A; Tokunaga M; Sugihara K; Kinugasa Y;
Int J Colorectal Dis; 2021 Jun; 36(6):1243-1250. PubMed ID: 33515308
[TBL] [Abstract][Full Text] [Related]
19. Locally recurrent rectal cancer and distant metastases: is there still a chance ofcure?
van Rees JM; Nordkamp S; Harmsen PW; Rutten H; Burger JWA; Verhoef C
Eur J Surg Oncol; 2023 Sep; 49(9):106865. PubMed ID: 37002176
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the location of local rectal cancer recurrence and predictors of survival.
Du P; Burke JP; Khoury W; Lavery IC; Kiran RP; Remzi FH; Dietz DW
Int J Colorectal Dis; 2016 Apr; 31(4):825-32. PubMed ID: 26861707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
